ATP1A3 and alternating hemiplegia of childhood: In Alternating Hemiplegia of Childhood (AHC), also associated with ATP1A3 mutations, flunarizine significantly reduced the frequency and severity of paroxysmal attacks and has become the most commonly used symptomatic treatment [34].